[Pericardial effusion in neoplasms and malignant hemopathies in children. Study of 12 cases and pathogenetic

G Balducci1, N Santoro, P Caliandro

  • 1Istituto di Pediatria Clinica e Preventiva dell'Università di Bari, Italia.

Insights

Pericardial effusion (P.E.) is uncommon in pediatric cancers, detected in 5.7% of cases via echocardiography. Early diagnosis and treatment of P.E. are crucial for improving outcomes in children with leukemia and solid tumors.

Area of Science:

  • Pediatric Oncology
  • Cardiology
  • Diagnostic Imaging

Context:

  • Pericardial effusion (P.E.) is a known complication of malignancies and leukemia.
  • The frequency of P.E. in pediatric cancer patients is not well-established.
  • Echocardiography enables detection of small P.E.s.

Purpose:

  • To determine the frequency of P.E. in children with malignant neoplasms and leukemia.
  • To evaluate the utility of echocardiography in diagnosing P.E. in this population.
  • To assess the clinical presentation and management of P.E. in pediatric cancer patients.

Summary:

  • A total of 265 echocardiograms were performed in 210 children with cancer or leukemia between 1981 and 1985.
  • 12 cases (5.7%) of P.E. were identified, most commonly in acute lymphatic leukemia (ALL) and rhabdomyosarcoma.
  • P.E. was often detected early, with some cases resolving after chemotherapy. Malignant cells were found in one patient's pericardial fluid.

Impact:

  • Echocardiography is effective in identifying P.E. in pediatric cancer patients.
  • P.E. occurs in a small but significant percentage of children with malignancies.
  • Findings highlight the importance of cardiac monitoring in pediatric cancer treatment.

Related Concept Videos

Pleural Effusion I: Introduction01:25

Pleural Effusion I: Introduction

Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's criteria,...
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Pericarditis I: Introduction01:22

Pericarditis I: Introduction

Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...